359 related articles for article (PubMed ID: 15471618)
1. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
[TBL] [Abstract][Full Text] [Related]
2. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone.
Andréen L; Spigset O; Andersson A; Nyberg S; Bäckström T
Maturitas; 2006 Jun; 54(3):238-44. PubMed ID: 16406399
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone.
Andréen L; Sundström-Poromaa I; Bixo M; Nyberg S; Bäckström T
Psychopharmacology (Berl); 2006 Aug; 187(2):209-21. PubMed ID: 16724185
[TBL] [Abstract][Full Text] [Related]
5. Allopregnanolone serum concentrations and neurosteroid sensitivity during withdrawal from postmenopausal hormone therapy.
Wihlbäck AC; Nyberg S; Andersson A; Bixo M; Bäckström T; Sundström-Poromaa I
Gynecol Endocrinol; 2007 Oct; 23(10):590-6. PubMed ID: 17852417
[TBL] [Abstract][Full Text] [Related]
6. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.
Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T
Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715
[TBL] [Abstract][Full Text] [Related]
8. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
Björn I; Bixo M; Nöjd KS; Collberg P; Nyberg S; Sundström-Poromaa I; Bäckström T
Gynecol Endocrinol; 2002 Feb; 16(1):1-8. PubMed ID: 11915576
[TBL] [Abstract][Full Text] [Related]
9. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels.
Bernardi F; Pluchino N; Pieri M; Begliuomini S; Lenzi E; Puccetti S; Casarosa E; Luisi M; Genazzani AR
Neuroendocrinology; 2006; 83(5-6):348-59. PubMed ID: 16931878
[TBL] [Abstract][Full Text] [Related]
10. Adverse mood effects during postmenopausal hormone treatment in relation to personality traits.
Björn I; Bäckström T; Lalos A; Sundström-Poromaa I
Climacteric; 2006 Aug; 9(4):290-7. PubMed ID: 16857659
[TBL] [Abstract][Full Text] [Related]
11. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
Limpaphayom KK; Bunyavejchevin S
J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
[TBL] [Abstract][Full Text] [Related]
13. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
[TBL] [Abstract][Full Text] [Related]
14. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
[TBL] [Abstract][Full Text] [Related]
15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
16. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
Pluchino N; Ninni F; Stomati M; Freschi L; Casarosa E; Valentino V; Luisi S; Genazzani AD; Potì E; Genazzani AR
Maturitas; 2008 Apr; 59(4):293-303. PubMed ID: 18394829
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
[TBL] [Abstract][Full Text] [Related]
18. Allopregnanolone and mood disorders.
Bäckström T; Bixo M; Johansson M; Nyberg S; Ossewaarde L; Ragagnin G; Savic I; Strömberg J; Timby E; van Broekhoven F; van Wingen G
Prog Neurobiol; 2014 Feb; 113():88-94. PubMed ID: 23978486
[TBL] [Abstract][Full Text] [Related]
19. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
Conner P; Skoog L; Söderqvist G
Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
[TBL] [Abstract][Full Text] [Related]
20. Progesterone effects during sequential hormone replacement therapy.
Andréen L; Bixo M; Nyberg S; Sundström-Poromaa I; Bäckström T
Eur J Endocrinol; 2003 May; 148(5):571-7. PubMed ID: 12720542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
